CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash Flows from Operating Activities
Net income	$ 54,180	$ 102,973
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	46,083	33,630
Deferred taxes	(11,761)	(17,073)
Stock-based compensation expenses	56,613	46,173
Gain from change in fair value of Warrants		(2,767)
Loss on warrant repurchase/redemption		14,746
Interest and amortization of discount on investments	(2,086)	(6,401)
Foreign currency re-measurement gain	(4,965)	(109)
Changes in operating assets and liabilities:
Other current assets	11,279	(36,277)
Trade payables	2,882	8,904
Deferred revenue	258	808
Accounts receivable, net	(2,405)	(1,255)
Capital advance extended to customers	(235,407)	(260,435)
Capital advance collected from customers	249,264	248,980
Other payables	1,394	(6,619)
Other long-term liabilities	13,086	(3,667)
Operating lease right-of-use assets	7,610	9,802
Other assets	(7,448)	(374)
Net cash provided by operating activities	178,577	131,039
Cash Flows from Investing Activities
Purchase of property, equipment and software	(12,285)	(4,449)
Capitalization of internal use software	(43,886)	(39,666)
Severance pay fund distributions, net	(56)	12
Customer funds in transit, net	(56,747)	(80,098)
Purchases of investments in available-for-sale debt securities	(351,824)	(1,255,686)
Maturities and sales of investments in available-for-sale debt securities	253,500	214,000
Purchases of investments in term deposits		(600,000)
Maturities of investments in term deposits	75,000
Cash paid in connection with acquisition, net of cash and customer funds acquired (refer to Note 3 for further information)	(33,081)	(48,219)
Net cash used in investing activities	(169,379)	(1,814,106)
Cash Flows from Financing Activities
Proceeds from issuance of common stock in connection with stock-based compensation plan, net of taxes paid related to settlement of equity awards and proceeds from employee equity transactions to be remitted to employees	(3,237)	23,015
Outstanding operating balances, net	136,622	(314,764)
Borrowings under debt facility		15,120
Repayments under debt facility		(20,312)
Receipts of collateral on interest rate derivatives	89,550
Payments of collateral on interest rate derivatives	(90,010)
Consideration related to previous acquisitions	455
Warrant repurchase/redemption		(19,534)
Payment on exercise of warrants	(1,332)
Common stock repurchased	(95,029)	(120,457)
Net cash provided by (used in) financing activities	37,019	(436,932)
Effect of exchange rate changes on cash and cash equivalents	5,177	109
Net change in cash, cash equivalents, restricted cash and customer funds	51,394	(2,119,890)
Cash, cash equivalents, restricted cash and customer funds at beginning of period	5,658,210	7,018,367
Cash, cash equivalents, restricted cash and customer funds at end of period	5,709,604	4,898,477
Supplemental information of investing and financing activities not involving cash flows:
Property, equipment, and software acquired but not paid	505	1,569
Internal use software capitalized but not paid	6,201	6,271
Common stock repurchased but not paid		150
Right of use assets obtained in exchange for new operating lease liabilities	$ 34,440	$ 6,533